Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dna X (SONM) Non Operating Income (2018 - 2025)

Dna X (SONM) has disclosed Non Operating Income for 8 consecutive years, with -$161000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Non Operating Income fell 747.37% year-over-year to -$161000.0, compared with a TTM value of $109000.0 through Sep 2025, up 153.43%, and an annual FY2024 reading of $246000.0, up 214.95% over the prior year.
  • Non Operating Income was -$161000.0 for Q3 2025 at Dna X, up from -$215000.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $601000.0 in Q4 2022 and bottomed at -$215000.0 in Q2 2025.
  • Average Non Operating Income over 5 years is -$14894.7, with a median of -$59000.0 recorded in 2023.
  • The sharpest move saw Non Operating Income plummeted 2166.67% in 2021, then surged 45000.0% in 2024.
  • Year by year, Non Operating Income stood at -$40000.0 in 2021, then surged by 1602.5% to $601000.0 in 2022, then crashed by 100.17% to -$1000.0 in 2023, then soared by 45000.0% to $449000.0 in 2024, then tumbled by 135.86% to -$161000.0 in 2025.
  • Business Quant data shows Non Operating Income for SONM at -$161000.0 in Q3 2025, -$215000.0 in Q2 2025, and $36000.0 in Q1 2025.